Until we learn to recognize susceptible infants and avert the immunologic response that results in asthma, we must improve the means by which we treat it.
John Browning, MD, explains dermatological questions to ask, answer in primary care
John Browning, MD, highlights why pediatricians should feel comfortable prescribing recent non-steroidals, and what questions to ask patients in office.
Food Insecurity and the Dangers of Infant Formula Dilution
A headache with a red flag in a 10-year-old girl
The patient described the headache as “pressure-like,” episodes that occurred for 1 to 2 hours with high severity.
Demystifying Infant Formula
Olivia is helping patients and families understand the experience of blood cancer
Phase 3 trial of omaveloxolone to treat Friedreich ataxia in children aged 2 to <16 begins
Currently, omaveloxolone (Skyclarys) is approved to treat adults and adolescents aged 16 years and older impacted by FA.